Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
In a recent study posted in the bioRxiv* preprint server, researchers explored the impact of a loss-of-function mutation in the ...
Individuals with Type 1 diabetes have a smaller pancreas than people without diabetes. This is surprising because insulin-producing beta cells ...
In a recent study published in PNAS, researchers demonstrated the structural basis of how the receptor-binding domain (RBD) nested Omicron ...
Adelaide researchers will use a $1 million grant to improve the diagnosis and treatment of blood cancers, which kill 16 ...
A study published in the journal Science Translational Medicine has described the transmissibility of severe acute respiratory syndrome coronavirus 2 ...
In a recent study posted to the medRxiv* preprint server, researchers assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the...
Read moreNEWS RELEASE: MGS MFG. Group acquires Danish product design firm Technolution Members of Technolution and MGS Mfg. Group GERMANTOWN, Wis....
Read moreIn a recent study published in the Nutrients Journal, researchers explored the phytochemical contents and health benefits of consuming figs....
Read moreDeviceTalks Editorial Director Tom Salemi (left) interviewed Boston Scientific CEO Mike Mahoney (right) in front of a crowd of medtech...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.